27 Sep 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Charles River Laboratories has appointed Mr John Crowley to the role of corporate senior VP, corporate controller and chief accounting officer (CAO), effective September 30, 2013.
In this newly created position, Mr Crowley will be responsible for providing strategic guidance to the finance groups, including directing the corporate accounting function and practices, maintaining its fiscal records and preparing its financial reports. He will also oversee the design and operation of the Charles River’s system of internal controls, ensuring compliance with the rules and regulations of the Sarbanes-Oxley Act.
Immediately prior to joining Charles River, Mr Crowley was VP, CAO and corporate controller of Ironwood Pharmaceuticals. Previously, he held senior corporate finance positions at Vertex Pharmaceuticals where he successfully managed and directed all areas of technical accounting.
Mr James C Foster, chairman, president, and CEO, Charles River Laboratories, commented that, “John brings a wealth of financial acumen to Charles River. His expertise and experience in the life sciences industry is a welcomed addition to our executive team.”
Mr Crowley commented, “Charles River has a compelling value proposition and a unique business model. I look forward to playing an integral role in its future growth and success.”